Clinical Trial Update: Factors Associated With End Stage Liver Disease

View source ↗

Summary

This clinical trial update notes that NCT01846819, sponsored by NYU Langone Health, investigating factors associated with end-stage liver disease in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• End-stage Liver Disease
• Hepatic Encephalopathy

Snippet

Sponsor: NYU Langone Health | Conditions: Cirrhosis, Hepatic Encephalopathy | Status: TERMINATED